Delta-Like Ligand 3 Expression by Immunohistochemistry in Rare Neuroendocrine Neoplasms and Associated Response to Off-Label Tarlatamab Treatment.
Saved in:
| Title: | Delta-Like Ligand 3 Expression by Immunohistochemistry in Rare Neuroendocrine Neoplasms and Associated Response to Off-Label Tarlatamab Treatment. |
|---|---|
| Authors: | Schieber T; The University of Kansas Cancer Center, Westwood, KS., Hobbs J; Avera McKennan Hospital and University Health Center /Avera Cancer Institute, Sioux Falls, SD., Campaign-Mauser J; Huntsman Cancer Institute, Salt Lake City, UT., Jones EJ; Huntsman Cancer Institute, Salt Lake City, UT., Olinger A; Nebraska Medical Center, Omaha, NE., Bortka B; Saint Luke's Hospital of Kansas City, Kansas City, MO., Gustafson B; Saint Luke's Hospital of Kansas City, Kansas City, MO., Blocker S; The University of Kansas Cancer Center, Westwood, KS., Kim D; The University of Kansas Cancer Center, Westwood, KS., Mullangi S; The University of Kansas Cancer Center, Westwood, KS., Lekkala MR; The University of Kansas Cancer Center, Westwood, KS., Parikh R; The University of Kansas Cancer Center, Westwood, KS., Huang C; The University of Kansas Cancer Center, Westwood, KS., Neupane P; The University of Kansas Cancer Center, Westwood, KS., Li H; The University of Kansas Cancer Center, Westwood, KS. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2026 Jan; Vol. 10, pp. e2500849. Date of Electronic Publication: 2026 Jan 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41576308 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Delta-Like Ligand 3 Expression by Immunohistochemistry in Rare Neuroendocrine Neoplasms and Associated Response to Off-Label Tarlatamab Treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schieber+T%22">Schieber T</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Hobbs+J%22">Hobbs J</searchLink>; Avera McKennan Hospital and University Health Center /Avera Cancer Institute, Sioux Falls, SD.<br /><searchLink fieldCode="AU" term="%22Campaign-Mauser+J%22">Campaign-Mauser J</searchLink>; Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Jones+EJ%22">Jones EJ</searchLink>; Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Olinger+A%22">Olinger A</searchLink>; Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Bortka+B%22">Bortka B</searchLink>; Saint Luke's Hospital of Kansas City, Kansas City, MO.<br /><searchLink fieldCode="AU" term="%22Gustafson+B%22">Gustafson B</searchLink>; Saint Luke's Hospital of Kansas City, Kansas City, MO.<br /><searchLink fieldCode="AU" term="%22Blocker+S%22">Blocker S</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Kim+D%22">Kim D</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Mullangi+S%22">Mullangi S</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Lekkala+MR%22">Lekkala MR</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Parikh+R%22">Parikh R</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Huang+C%22">Huang C</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Neupane+P%22">Neupane P</searchLink>; The University of Kansas Cancer Center, Westwood, KS.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; The University of Kansas Cancer Center, Westwood, KS. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2026 Jan; Vol. 10, pp. e2500849. <i>Date of Electronic Publication: </i>2026 Jan 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41576308 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/PO-25-00849 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2500849 Titles: – TitleFull: Delta-Like Ligand 3 Expression by Immunohistochemistry in Rare Neuroendocrine Neoplasms and Associated Response to Off-Label Tarlatamab Treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schieber T – PersonEntity: Name: NameFull: Hobbs J – PersonEntity: Name: NameFull: Campaign-Mauser J – PersonEntity: Name: NameFull: Jones EJ – PersonEntity: Name: NameFull: Olinger A – PersonEntity: Name: NameFull: Bortka B – PersonEntity: Name: NameFull: Gustafson B – PersonEntity: Name: NameFull: Blocker S – PersonEntity: Name: NameFull: Kim D – PersonEntity: Name: NameFull: Mullangi S – PersonEntity: Name: NameFull: Lekkala MR – PersonEntity: Name: NameFull: Parikh R – PersonEntity: Name: NameFull: Huang C – PersonEntity: Name: NameFull: Neupane P – PersonEntity: Name: NameFull: Li H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-4284 Numbering: – Type: volume Value: 10 Titles: – TitleFull: JCO precision oncology Type: main |
| ResultId | 1 |